Clinical Trials Logo

Clinical Trial Summary

Does a group programme already delivered in routine practice to patients who share a diagnosis from the same medical speciality (i.e. specific-diagnosis) show equal effectiveness when modified for patients with diagnoses from a range of medical specialities (i.e. mixed-diagnosis)? A large number of people live with a long-term condition (LTC) and the burden of living with a LTC is recognised on a societal and individual level. Links between LTCs and poorer mental health increase demand on psychological services. Consequently new initiatives try to reduce waiting times and increase the capacity of these services. Group programmes use resources efficiently and have been applied across a range of medical specialities. A clinical health psychology service has adopted a group programme based on a well evidenced psychological therapeutic approach called Acceptance and Commitment Therapy (ACT), for patients with dermatology conditions showing promising outcomes. However, the investigators want to compare whether similar outcomes can be achieved with patients from a range of specialities. The investigators conducted quantitative and qualitative research to answer the research questions a) Does an Acceptance and Commitment Therapy group intervention for specific-diagnosis groups suggest similar effectiveness in health-related quality of life, illness beliefs and psychological distress versus mixed-diagnosis groups? b) Is there a difference in feasibility and acceptability of an Acceptance and Commitment Therapy intervention between specific-diagnosis groups versus mixed-diagnosis groups? c) What are health professionals' views on the acceptability and feasibility of specific-diagnosis versus mixed-diagnosis groups and their experiences of working with patients who have attended such groups? Participants were recruited from the Clinical Health Psychology waiting list at a UK NHS Trust. Participants attended 7, two-hour weekly sessions and an 8 week follow-up 'reunion', and completed health related quality of life, illness perceptions, depression and anxiety questionnaires pre and post intervention. Patient participants and health professional participants (facilitators and referrers) were invited to attend focus groups to discuss their views and experiences.


Clinical Trial Description

Design A mixed methods pilot and feasibility study was selected and applied. Mixed methods were selected as it integrates rich and comprehensive data from a quantitative and qualitative approach, to answer the overall studies research questions: 1. Is there a difference in feasibility and acceptability of an online ACT intervention between specific-diagnosis versus mixed-diagnosis groups? 2. What are health professionals' views on the acceptability and feasibility of specific-diagnosis versus mixed-diagnosis groups and their experiences of working with patients who have attended such groups? 3. Do the results of this small pilot and feasibility study suggest similar effectiveness in health-related quality of life, illness beliefs and psychological distress in specific-diagnosis versus mixed-diagnosis groups? We delivered online groups. Quantitative data collected from attendance records, and qualitative data collected from qualitative interviews with participants who took part in the intervention, addressed research question 1. Qualitative data collected from qualitative interviews with health professionals who facilitated the intervention, and health professionals who referred patients to the intervention, addressed research question 2. Finally, quantitative data collected from psychometric measures, addressed the third research question. Study participants Patient participants were recruited from the Clinical Health Psychology GM team waiting list, or by being made aware of the groups by health professionals working within specialities covered by the GM team. As per routine clinical practice, patients on the waiting list were invited to attend the group intervention via letter or during a routine waiting list check-in review. The waiting list was regularly reviewed so for each scheduled group, only new appropriate patients on the waiting list were sent invites (i.e., each patient only received one invite to respect their choice not to participate). We had planned for potential patient participants to be able to self-refer to the clinical team. Self-referrals were expected from patients who saw an advertising poster placed in the waiting rooms of the hospital specialties the GM team covered. Since face-to-face healthcare was extremely limited during the recruitment period, posters were not used. All interested participants received a telephone screening consultation, including a brief psychological assessment, to check each participant was suitable and that they met inclusion criteria. This assessment informed patients about the research study in line with details provided in the participant information sheet. If after this telephone screening assessment with a clinical team member a participant met the inclusion criteria, and wished to continue, they were allocated to the intervention and invited into one of the group conditions, dependent on their diagnosis. Written consent was obtained at the start of the intervention. The group intervention was still offered to any patient who did not want to take part in the research. If a patient was not suitable, they were offered appropriate alternative treatment as deemed necessary by the assessing clinician. At the last session of the intervention, patient participants recruited to the research were invited via email to take part in a qualitative interview to explore their views and experiences. Two types of health professional participants were recruited: (A) Those who facilitated/delivered the intervention (B) Those who referred patients to the intervention Facilitators were invited via email to take part in an online focus group, and referrers were invited via email to take part in online individual interviews. These explored health professional participants views of the intervention and experiences of working with patients in relation to the groups. The only facilitator who was excluded from participating was the main researcher due to potential researcher bias. All health professional participants were informed about the research study and given a participant information sheet, prior to consenting to take part. Procedure The online ACT group intervention was delivered to two group conditions, specific-diagnosis and mixed-diagnosis. Each group condition had four intervention group programmes, totaling eight groups overall. Prior to the COVID-19 pandemic it was standard practice to deliver groups face-to-face, however, government enforced restrictions meant that this was not allowed particularly during national lockdowns. Hence the delivery format was changed to online. The ACT group intervention was called 'Living Well with a Long-Term Condition' and was adapted from the Brassington et al., (2016) 'Better Living with Illness' protocol. A clinician handbook, and participant workbook , was developed that could be used for both group conditions. These materials were adapted by the researcher and other members of the GM team, all of whom had received specialist training in ACT. Each group was delivered online using a platform called 'Microsoft Teams'. The intervention was facilitated by two qualified clinicians. The intervention consisted of 8, 2-hour sessions. Sessions 1-7 were delivered on a weekly basis, followed by a gap of 8 weeks, before the final 'reunion' session. In summary the sessions covered the six core processes of ACT, included experiential exercises, and allowed for group discussions to share experiences and learning between participants. Online 'screen share' materials were developed so that facilitators could guide participants through the session content. Microsoft teams had features that were utilised to support the group sessions such as camera, mute, raise hand, text chat and share screen functions. Participants were encouraged to have their camera on during group sessions, but it was not mandatory (to respect privacy and confidentiality). At the end of the sessions, facilitators remained logged into the meeting for 15 minutes, to allow for any participants to answer questions privately. Telephone calls were also offered, should any participants have any questions which could be requested via email. Summary emails were sent following each session which included links to access any exercises as part of their home-practice between sessions. Participants who missed sessions were signposted to read through information provided in their participant workbook and offered a telephone consultation to talk through any missed content. It was decided that if anyone missed the first two sessions consecutively, they were transferred to the next mixed-diagnosis group available or returned to the waiting list. This decision was based on the potential to cause disruption to the group dynamics, whereby social relationships would likely have already been established, making it difficult for a new person to interact with the group and feel part of the 'group spirit', which may also negatively impact a patient's own wellbeing. Unfortunately, resources did not allow multiple specific-diagnosis groups to run hence the option to transfer to another specific-diagnosis group was not possible. Measures Psychometric questionnaires were completed by patient participants to assess psychological distress, illness perceptions and health-related quality of life at three different timepoints, baseline (pre-treatment), session 7 (post-treatment) and session 8 (8-week follow-up). Other quantitative measures to assess the feasibility and acceptability of the intervention to the patient participants included eligibility, recruitment, retention, true completion, and intervention adherence rates. We collected qualitative data with patient participants and health professional participants. Patient qualitative interviews Patient participants who had consented to take part in the research were invited via email to take part in online focus groups and individual interviews using microsoft teams. These were moderated by a research assistant who had an honorary contract as a volunteer assistant psychologist with the Clinical Health Psychology service. The research assistant was provided with training on how to conduct focus groups and individual interviews, and was supervised by the main researcher, who had prior qualitative research experience. Originally four focus groups were planned, two for each of the group conditions. To improve recruitment an amendment to the ethics was approved (20/NW/0125/AM01), to include individual interviews as well as focus groups to collect qualitative data from any participants who had been unable to take part in focus groups. Both interviews and focus groups are an evidenced based method of data collection for qualitative studies (Harrell & Bradley, 2009), the pros and cons for both were considered, and it was concluded that this additional alternative method of data collection allowed for greater flexibility to arrange interviews at times to suit all participants busy schedules. Participants were invited via email by the researcher and were given a participant information sheet. Those who took part provided written consent. All qualitative interviews were audio-recorded, focus groups lasted no longer than 2 hours and individual interviews lasted no longer than 30 minutes. A topic guide was used to elicit participants views and experiences of taking part in the intervention, as well as thoughts on the intervention being delivered to the two group conditions. Health professional interview One focus group was conducted with the facilitators of the intervention. Individual interviews were conducted with the referrers. All qualitative interviews were held online using microsoft teams and moderated by the same research assistant as above. All health professionals were invited via email and given participant information sheets explaining that the focus group would last no longer than one hour and individual interviews no longer than 30 minutes. Two topic guides were developed, to gather the views and experiences of health professionals including their thoughts on the two group conditions. All health professionals who agreed to take part provided written consent and all qualitative interviews were audio-recorded. Quantitative data A mixed 2 by 3 ANOVA analysis was used, to compare the mean differences between groups on the outcome measures. These were split on a between subjects' factors (group condition), and a within subjects' factor (time, with three timepoints; T1-baseline, T2-post treatment and T3-8 weeks follow-up), with data assessed for homogeneity, normality and sphericity, and appropriate adjustments made when assumptions were violated. Descriptive statistics reported eligibility, recruitment, retention, true completion, and intervention adherence rates. Qualitative data Qualitative data was analysed aligned to a deductive and inductive, reflexive thematic analysis approach (Braun & Clarke, 2006; 2019, 2020). This commonly used hybrid approach was deemed appropriate, to best meet the aims of the study and answer research questions. Initially a theory-driven concept, the TFA , was applied for the process of deductive thematic analysis. Following this an inductive approach allowed the development of themes from the data and allowed for a broader understanding of the data. It is acknowledged that the coding approach was collaborative (as it involved multiple researchers) and reflexive whereby researchers' 'read' the data based on personal theoretical assumptions, analytic resources and skill. Thus, interpretations reflect those of the researchers' own experiences, beliefs and biases which will have affected the development and generation of themes and inferences. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05402358
Study type Observational
Source University of Stirling
Contact
Status Completed
Phase
Start date June 1, 2020
Completion date November 30, 2021

See also
  Status Clinical Trial Phase
Completed NCT05594446 - Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
Completed NCT03975309 - DHS MIND Metabolomics
Completed NCT01855399 - Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes N/A
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Recruiting NCT05007990 - Caregiving Networks Across Disease Context and the Life Course
Active, not recruiting NCT04420936 - Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program N/A
Recruiting NCT03549559 - Imaging Histone Deacetylase in the Heart N/A
Completed NCT04903496 - Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
Completed NCT01437592 - Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects Phase 1
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT03390179 - Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Recruiting NCT05294822 - Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes N/A
Completed NCT04427982 - Dance and Diabetes/Prediabetes Self-Management N/A
Completed NCT02356848 - STEP UP to Avert Amputation in Diabetes N/A
Completed NCT03292185 - A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects Phase 1
Active, not recruiting NCT05477368 - Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes N/A
Completed NCT04496401 - PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus Phase 4